Table of Content

1 Study Coverage
1.1 Non-Benzodiazepines Product Introduction
1.2 Market by Type
1.2.1 Global Non-Benzodiazepines Market Size Growth Rate by Type, 2024 VS 2022 VS 2034
1.2.2 Dexmedetomidine
1.2.3 Zolpidem
1.2.4 Eszopiclone
1.2.5 Zopiclone
1.2.6 other
1.3 Market by Application
1.3.1 Global Non-Benzodiazepines Market Size Growth Rate by Application, 2024 VS 2022 VS 2034
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Non-Benzodiazepines Sales Estimates and Forecasts 2024-2034
2.2 Global Non-Benzodiazepines Revenue by Region
2.2.1 Global Non-Benzodiazepines Revenue by Region: 2024 VS 2022 VS 2034
2.2.2 Global Non-Benzodiazepines Revenue by Region (2024-2024)
2.2.3 Global Non-Benzodiazepines Revenue by Region (2024-2034)
2.2.4 Global Non-Benzodiazepines Revenue Market Share by Region (2024-2034)
2.3 Global Non-Benzodiazepines Sales Estimates and Forecasts 2024-2034
2.4 Global Non-Benzodiazepines Sales by Region
2.4.1 Global Non-Benzodiazepines Sales by Region: 2024 VS 2022 VS 2034
2.4.2 Global Non-Benzodiazepines Sales by Region (2024-2024)
2.4.3 Global Non-Benzodiazepines Sales by Region (2024-2034)
2.4.4 Global Non-Benzodiazepines Sales Market Share by Region (2024-2034)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Non-Benzodiazepines Sales by Manufacturers
3.1.1 Global Non-Benzodiazepines Sales by Manufacturers (2024-2024)
3.1.2 Global Non-Benzodiazepines Sales Market Share by Manufacturers (2024-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Non-Benzodiazepines in 2022
3.2 Global Non-Benzodiazepines Revenue by Manufacturers
3.2.1 Global Non-Benzodiazepines Revenue by Manufacturers (2024-2024)
3.2.2 Global Non-Benzodiazepines Revenue Market Share by Manufacturers (2024-2024)
3.2.3 Global Top 10 and Top 5 Companies by Non-Benzodiazepines Revenue in 2022
3.3 Global Key Players of Non-Benzodiazepines, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Non-Benzodiazepines Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Non-Benzodiazepines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Non-Benzodiazepines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Non-Benzodiazepines, Product Offered and Application
3.8 Global Key Manufacturers of Non-Benzodiazepines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Non-Benzodiazepines Sales by Type
4.1.1 Global Non-Benzodiazepines Historical Sales by Type (2024-2024)
4.1.2 Global Non-Benzodiazepines Forecasted Sales by Type (2024-2034)
4.1.3 Global Non-Benzodiazepines Sales Market Share by Type (2024-2034)
4.2 Global Non-Benzodiazepines Revenue by Type
4.2.1 Global Non-Benzodiazepines Historical Revenue by Type (2024-2024)
4.2.2 Global Non-Benzodiazepines Forecasted Revenue by Type (2024-2034)
4.2.3 Global Non-Benzodiazepines Revenue Market Share by Type (2024-2034)
4.3 Global Non-Benzodiazepines Price by Type
4.3.1 Global Non-Benzodiazepines Price by Type (2024-2024)
4.3.2 Global Non-Benzodiazepines Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Non-Benzodiazepines Sales by Application
5.1.1 Global Non-Benzodiazepines Historical Sales by Application (2024-2024)
5.1.2 Global Non-Benzodiazepines Forecasted Sales by Application (2024-2034)
5.1.3 Global Non-Benzodiazepines Sales Market Share by Application (2024-2034)
5.2 Global Non-Benzodiazepines Revenue by Application
5.2.1 Global Non-Benzodiazepines Historical Revenue by Application (2024-2024)
5.2.2 Global Non-Benzodiazepines Forecasted Revenue by Application (2024-2034)
5.2.3 Global Non-Benzodiazepines Revenue Market Share by Application (2024-2034)
5.3 Global Non-Benzodiazepines Price by Application
5.3.1 Global Non-Benzodiazepines Price by Application (2024-2024)
5.3.2 Global Non-Benzodiazepines Price Forecast by Application (2024-2034)
6 US & Canada
6.1 US & Canada Non-Benzodiazepines Market Size by Type
6.1.1 US & Canada Non-Benzodiazepines Sales by Type (2024-2034)
6.1.2 US & Canada Non-Benzodiazepines Revenue by Type (2024-2034)
6.2 US & Canada Non-Benzodiazepines Market Size by Application
6.2.1 US & Canada Non-Benzodiazepines Sales by Application (2024-2034)
6.2.2 US & Canada Non-Benzodiazepines Revenue by Application (2024-2034)
6.3 US & Canada Non-Benzodiazepines Market Size by Country
6.3.1 US & Canada Non-Benzodiazepines Revenue by Country: 2024 VS 2022 VS 2034
6.3.2 US & Canada Non-Benzodiazepines Sales by Country (2024-2034)
6.3.3 US & Canada Non-Benzodiazepines Revenue by Country (2024-2034)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Non-Benzodiazepines Market Size by Type
7.1.1 Europe Non-Benzodiazepines Sales by Type (2024-2034)
7.1.2 Europe Non-Benzodiazepines Revenue by Type (2024-2034)
7.2 Europe Non-Benzodiazepines Market Size by Application
7.2.1 Europe Non-Benzodiazepines Sales by Application (2024-2034)
7.2.2 Europe Non-Benzodiazepines Revenue by Application (2024-2034)
7.3 Europe Non-Benzodiazepines Market Size by Country
7.3.1 Europe Non-Benzodiazepines Revenue by Country: 2024 VS 2022 VS 2034
7.3.2 Europe Non-Benzodiazepines Sales by Country (2024-2034)
7.3.3 Europe Non-Benzodiazepines Revenue by Country (2024-2034)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Non-Benzodiazepines Market Size
8.1.1 China Non-Benzodiazepines Sales (2024-2034)
8.1.2 China Non-Benzodiazepines Revenue (2024-2034)
8.2 China Non-Benzodiazepines Market Size by Application
8.2.1 China Non-Benzodiazepines Sales by Application (2024-2034)
8.2.2 China Non-Benzodiazepines Revenue by Application (2024-2034)
9 Asia (excluding China)
9.1 Asia Non-Benzodiazepines Market Size by Type
9.1.1 Asia Non-Benzodiazepines Sales by Type (2024-2034)
9.1.2 Asia Non-Benzodiazepines Revenue by Type (2024-2034)
9.2 Asia Non-Benzodiazepines Market Size by Application
9.2.1 Asia Non-Benzodiazepines Sales by Application (2024-2034)
9.2.2 Asia Non-Benzodiazepines Revenue by Application (2024-2034)
9.3 Asia Non-Benzodiazepines Sales by Region
9.3.1 Asia Non-Benzodiazepines Revenue by Region: 2024 VS 2022 VS 2034
9.3.2 Asia Non-Benzodiazepines Revenue by Region (2024-2034)
9.3.3 Asia Non-Benzodiazepines Sales by Region (2024-2034)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Non-Benzodiazepines Market Size by Type
10.1.1 Middle East, Africa and Latin America Non-Benzodiazepines Sales by Type (2024-2034)
10.1.2 Middle East, Africa and Latin America Non-Benzodiazepines Revenue by Type (2024-2034)
10.2 Middle East, Africa and Latin America Non-Benzodiazepines Market Size by Application
10.2.1 Middle East, Africa and Latin America Non-Benzodiazepines Sales by Application (2024-2034)
10.2.2 Middle East, Africa and Latin America Non-Benzodiazepines Revenue by Application (2024-2034)
10.3 Middle East, Africa and Latin America Non-Benzodiazepines Sales by Country
10.3.1 Middle East, Africa and Latin America Non-Benzodiazepines Revenue by Country: 2024 VS 2022 VS 2034
10.3.2 Middle East, Africa and Latin America Non-Benzodiazepines Revenue by Country (2024-2034)
10.3.3 Middle East, Africa and Latin America Non-Benzodiazepines Sales by Country (2024-2034)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Non-Benzodiazepines Sales, Price, Revenue and Gross Margin (2024-2024)
11.1.4 Pfizer Non-Benzodiazepines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Teva Pharmaceuticals
11.2.1 Teva Pharmaceuticals Company Information
11.2.2 Teva Pharmaceuticals Overview
11.2.3 Teva Pharmaceuticals Non-Benzodiazepines Sales, Price, Revenue and Gross Margin (2024-2024)
11.2.4 Teva Pharmaceuticals Non-Benzodiazepines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Teva Pharmaceuticals Recent Developments
11.3 Torrent Pharma
11.3.1 Torrent Pharma Company Information
11.3.2 Torrent Pharma Overview
11.3.3 Torrent Pharma Non-Benzodiazepines Sales, Price, Revenue and Gross Margin (2024-2024)
11.3.4 Torrent Pharma Non-Benzodiazepines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Torrent Pharma Recent Developments
11.4 Accord Healthcare
11.4.1 Accord Healthcare Company Information
11.4.2 Accord Healthcare Overview
11.4.3 Accord Healthcare Non-Benzodiazepines Sales, Price, Revenue and Gross Margin (2024-2024)
11.4.4 Accord Healthcare Non-Benzodiazepines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Accord Healthcare Recent Developments
11.5 Akorn
11.5.1 Akorn Company Information
11.5.2 Akorn Overview
11.5.3 Akorn Non-Benzodiazepines Sales, Price, Revenue and Gross Margin (2024-2024)
11.5.4 Akorn Non-Benzodiazepines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Akorn Recent Developments
11.6 Apotex
11.6.1 Apotex Company Information
11.6.2 Apotex Overview
11.6.3 Apotex Non-Benzodiazepines Sales, Price, Revenue and Gross Margin (2024-2024)
11.6.4 Apotex Non-Benzodiazepines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Apotex Recent Developments
11.7 Fresenius Kabi
11.7.1 Fresenius Kabi Company Information
11.7.2 Fresenius Kabi Overview
11.7.3 Fresenius Kabi Non-Benzodiazepines Sales, Price, Revenue and Gross Margin (2024-2024)
11.7.4 Fresenius Kabi Non-Benzodiazepines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Fresenius Kabi Recent Developments
11.8 Hikma
11.8.1 Hikma Company Information
11.8.2 Hikma Overview
11.8.3 Hikma Non-Benzodiazepines Sales, Price, Revenue and Gross Margin (2024-2024)
11.8.4 Hikma Non-Benzodiazepines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Hikma Recent Developments
11.9 Mylan
11.9.1 Mylan Company Information
11.9.2 Mylan Overview
11.9.3 Mylan Non-Benzodiazepines Sales, Price, Revenue and Gross Margin (2024-2024)
11.9.4 Mylan Non-Benzodiazepines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Mylan Recent Developments
11.10 Par Pharmaceuticals
11.10.1 Par Pharmaceuticals Company Information
11.10.2 Par Pharmaceuticals Overview
11.10.3 Par Pharmaceuticals Non-Benzodiazepines Sales, Price, Revenue and Gross Margin (2024-2024)
11.10.4 Par Pharmaceuticals Non-Benzodiazepines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Par Pharmaceuticals Recent Developments
11.11 Sandoz
11.11.1 Sandoz Company Information
11.11.2 Sandoz Overview
11.11.3 Sandoz Non-Benzodiazepines Sales, Price, Revenue and Gross Margin (2024-2024)
11.11.4 Sandoz Non-Benzodiazepines Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Sandoz Recent Developments
11.12 Sun Pharma
11.12.1 Sun Pharma Company Information
11.12.2 Sun Pharma Overview
11.12.3 Sun Pharma Non-Benzodiazepines Sales, Price, Revenue and Gross Margin (2024-2024)
11.12.4 Sun Pharma Non-Benzodiazepines Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Sun Pharma Recent Developments
11.13 WG Critical Care
11.13.1 WG Critical Care Company Information
11.13.2 WG Critical Care Overview
11.13.3 WG Critical Care Non-Benzodiazepines Sales, Price, Revenue and Gross Margin (2024-2024)
11.13.4 WG Critical Care Non-Benzodiazepines Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 WG Critical Care Recent Developments
11.14 Athenex
11.14.1 Athenex Company Information
11.14.2 Athenex Overview
11.14.3 Athenex Non-Benzodiazepines Sales, Price, Revenue and Gross Margin (2024-2024)
11.14.4 Athenex Non-Benzodiazepines Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Athenex Recent Developments
11.15 Chenxin Pharmaceutical
11.15.1 Chenxin Pharmaceutical Company Information
11.15.2 Chenxin Pharmaceutical Overview
11.15.3 Chenxin Pharmaceutical Non-Benzodiazepines Sales, Price, Revenue and Gross Margin (2024-2024)
11.15.4 Chenxin Pharmaceutical Non-Benzodiazepines Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Chenxin Pharmaceutical Recent Developments
11.16 Huatai Chenguang Pharmaceutical
11.16.1 Huatai Chenguang Pharmaceutical Company Information
11.16.2 Huatai Chenguang Pharmaceutical Overview
11.16.3 Huatai Chenguang Pharmaceutical Non-Benzodiazepines Sales, Price, Revenue and Gross Margin (2024-2024)
11.16.4 Huatai Chenguang Pharmaceutical Non-Benzodiazepines Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Huatai Chenguang Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Non-Benzodiazepines Industry Chain Analysis
12.2 Non-Benzodiazepines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Non-Benzodiazepines Production Mode & Process
12.4 Non-Benzodiazepines Sales and Marketing
12.4.1 Non-Benzodiazepines Sales Channels
12.4.2 Non-Benzodiazepines Distributors
12.5 Non-Benzodiazepines Customers
13 Market Dynamics
13.1 Non-Benzodiazepines Industry Trends
13.2 Non-Benzodiazepines Market Drivers
13.3 Non-Benzodiazepines Market Challenges
13.4 Non-Benzodiazepines Market Restraints
14 Key Findings in The Global Non-Benzodiazepines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Non-Benzodiazepines Market Size Growth Rate by Type, 2024 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Dexmedetomidine
Table 3. Major Manufacturers of Zolpidem
Table 4. Major Manufacturers of Eszopiclone
Table 5. Major Manufacturers of Zopiclone
Table 6. Major Manufacturers of other
Table 7. Global Non-Benzodiazepines Market Size Growth Rate by Application, 2024 VS 2022 VS 2034 (US$ Million)
Table 8. Global Non-Benzodiazepines Revenue Grow Rate (CAGR) by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 9. Global Non-Benzodiazepines Revenue by Region (2024-2024) & (US$ Million)
Table 10. Global Non-Benzodiazepines Revenue by Region (2024-2034) & (US$ Million)
Table 11. Global Non-Benzodiazepines Revenue Market Share by Region (2024-2024)
Table 12. Global Non-Benzodiazepines Revenue Market Share by Region (2024-2034)
Table 13. Global Non-Benzodiazepines Sales Grow Rate (CAGR) by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 14. Global Non-Benzodiazepines Sales by Region (2024-2024) & (K Units)
Table 15. Global Non-Benzodiazepines Sales by Region (2024-2034) & (K Units)
Table 16. Global Non-Benzodiazepines Sales Market Share by Region (2024-2024)
Table 17. Global Non-Benzodiazepines Sales Market Share by Region (2024-2034)
Table 18. Global Non-Benzodiazepines Sales by Manufacturers (2024-2024) & (K Units)
Table 19. Global Non-Benzodiazepines Sales Share by Manufacturers (2024-2024)
Table 20. Global Non-Benzodiazepines Revenue by Manufacturers (2024-2024) & (US$ Million)
Table 21. Global Non-Benzodiazepines Revenue Share by Manufacturers (2024-2024)
Table 22. Global Key Players of Non-Benzodiazepines, Industry Ranking, 2021 VS 2022 VS 2024
Table 23. Non-Benzodiazepines Price by Manufacturers 2024-2024 (US$/Unit)
Table 24. Global Non-Benzodiazepines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Non-Benzodiazepines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Benzodiazepines as of 2022)
Table 26. Global Key Manufacturers of Non-Benzodiazepines, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Non-Benzodiazepines, Product Offered and Application
Table 28. Global Key Manufacturers of Non-Benzodiazepines, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Non-Benzodiazepines Sales by Type (2024-2024) & (K Units)
Table 31. Global Non-Benzodiazepines Sales by Type (2024-2034) & (K Units)
Table 32. Global Non-Benzodiazepines Sales Share by Type (2024-2024)
Table 33. Global Non-Benzodiazepines Sales Share by Type (2024-2034)
Table 34. Global Non-Benzodiazepines Revenue by Type (2024-2024) & (US$ Million)
Table 35. Global Non-Benzodiazepines Revenue by Type (2024-2034) & (US$ Million)
Table 36. Global Non-Benzodiazepines Revenue Share by Type (2024-2024)
Table 37. Global Non-Benzodiazepines Revenue Share by Type (2024-2034)
Table 38. Non-Benzodiazepines Price by Type (2024-2024) & (US$/Unit)
Table 39. Global Non-Benzodiazepines Price Forecast by Type (2024-2034) & (US$/Unit)
Table 40. Global Non-Benzodiazepines Sales by Application (2024-2024) & (K Units)
Table 41. Global Non-Benzodiazepines Sales by Application (2024-2034) & (K Units)
Table 42. Global Non-Benzodiazepines Sales Share by Application (2024-2024)
Table 43. Global Non-Benzodiazepines Sales Share by Application (2024-2034)
Table 44. Global Non-Benzodiazepines Revenue by Application (2024-2024) & (US$ Million)
Table 45. Global Non-Benzodiazepines Revenue by Application (2024-2034) & (US$ Million)
Table 46. Global Non-Benzodiazepines Revenue Share by Application (2024-2024)
Table 47. Global Non-Benzodiazepines Revenue Share by Application (2024-2034)
Table 48. Non-Benzodiazepines Price by Application (2024-2024) & (US$/Unit)
Table 49. Global Non-Benzodiazepines Price Forecast by Application (2024-2034) & (US$/Unit)
Table 50. US & Canada Non-Benzodiazepines Sales by Type (2024-2024) & (K Units)
Table 51. US & Canada Non-Benzodiazepines Sales by Type (2024-2034) & (K Units)
Table 52. US & Canada Non-Benzodiazepines Revenue by Type (2024-2024) & (US$ Million)
Table 53. US & Canada Non-Benzodiazepines Revenue by Type (2024-2034) & (US$ Million)
Table 54. US & Canada Non-Benzodiazepines Sales by Application (2024-2024) & (K Units)
Table 55. US & Canada Non-Benzodiazepines Sales by Application (2024-2034) & (K Units)
Table 56. US & Canada Non-Benzodiazepines Revenue by Application (2024-2024) & (US$ Million)
Table 57. US & Canada Non-Benzodiazepines Revenue by Application (2024-2034) & (US$ Million)
Table 58. US & Canada Non-Benzodiazepines Revenue Grow Rate (CAGR) by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 59. US & Canada Non-Benzodiazepines Revenue by Country (2024-2024) & (US$ Million)
Table 60. US & Canada Non-Benzodiazepines Revenue by Country (2024-2034) & (US$ Million)
Table 61. US & Canada Non-Benzodiazepines Sales by Country (2024-2024) & (K Units)
Table 62. US & Canada Non-Benzodiazepines Sales by Country (2024-2034) & (K Units)
Table 63. Europe Non-Benzodiazepines Sales by Type (2024-2024) & (K Units)
Table 64. Europe Non-Benzodiazepines Sales by Type (2024-2034) & (K Units)
Table 65. Europe Non-Benzodiazepines Revenue by Type (2024-2024) & (US$ Million)
Table 66. Europe Non-Benzodiazepines Revenue by Type (2024-2034) & (US$ Million)
Table 67. Europe Non-Benzodiazepines Sales by Application (2024-2024) & (K Units)
Table 68. Europe Non-Benzodiazepines Sales by Application (2024-2034) & (K Units)
Table 69. Europe Non-Benzodiazepines Revenue by Application (2024-2024) & (US$ Million)
Table 70. Europe Non-Benzodiazepines Revenue by Application (2024-2034) & (US$ Million)
Table 71. Europe Non-Benzodiazepines Revenue Grow Rate (CAGR) by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 72. Europe Non-Benzodiazepines Revenue by Country (2024-2024) & (US$ Million)
Table 73. Europe Non-Benzodiazepines Revenue by Country (2024-2034) & (US$ Million)
Table 74. Europe Non-Benzodiazepines Sales by Country (2024-2024) & (K Units)
Table 75. Europe Non-Benzodiazepines Sales by Country (2024-2034) & (K Units)
Table 76. China Non-Benzodiazepines Sales by Type (2024-2024) & (K Units)
Table 77. China Non-Benzodiazepines Sales by Type (2024-2034) & (K Units)
Table 78. China Non-Benzodiazepines Revenue by Type (2024-2024) & (US$ Million)
Table 79. China Non-Benzodiazepines Revenue by Type (2024-2034) & (US$ Million)
Table 80. China Non-Benzodiazepines Sales by Application (2024-2024) & (K Units)
Table 81. China Non-Benzodiazepines Sales by Application (2024-2034) & (K Units)
Table 82. China Non-Benzodiazepines Revenue by Application (2024-2024) & (US$ Million)
Table 83. China Non-Benzodiazepines Revenue by Application (2024-2034) & (US$ Million)
Table 84. Asia Non-Benzodiazepines Sales by Type (2024-2024) & (K Units)
Table 85. Asia Non-Benzodiazepines Sales by Type (2024-2034) & (K Units)
Table 86. Asia Non-Benzodiazepines Revenue by Type (2024-2024) & (US$ Million)
Table 87. Asia Non-Benzodiazepines Revenue by Type (2024-2034) & (US$ Million)
Table 88. Asia Non-Benzodiazepines Sales by Application (2024-2024) & (K Units)
Table 89. Asia Non-Benzodiazepines Sales by Application (2024-2034) & (K Units)
Table 90. Asia Non-Benzodiazepines Revenue by Application (2024-2024) & (US$ Million)
Table 91. Asia Non-Benzodiazepines Revenue by Application (2024-2034) & (US$ Million)
Table 92. Asia Non-Benzodiazepines Revenue Grow Rate (CAGR) by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 93. Asia Non-Benzodiazepines Revenue by Region (2024-2024) & (US$ Million)
Table 94. Asia Non-Benzodiazepines Revenue by Region (2024-2034) & (US$ Million)
Table 95. Asia Non-Benzodiazepines Sales by Region (2024-2024) & (K Units)
Table 96. Asia Non-Benzodiazepines Sales by Region (2024-2034) & (K Units)
Table 97. Middle East, Africa and Latin America Non-Benzodiazepines Sales by Type (2024-2024) & (K Units)
Table 98. Middle East, Africa and Latin America Non-Benzodiazepines Sales by Type (2024-2034) & (K Units)
Table 99. Middle East, Africa and Latin America Non-Benzodiazepines Revenue by Type (2024-2024) & (US$ Million)
Table 100. Middle East, Africa and Latin America Non-Benzodiazepines Revenue by Type (2024-2034) & (US$ Million)
Table 101. Middle East, Africa and Latin America Non-Benzodiazepines Sales by Application (2024-2024) & (K Units)
Table 102. Middle East, Africa and Latin America Non-Benzodiazepines Sales by Application (2024-2034) & (K Units)
Table 103. Middle East, Africa and Latin America Non-Benzodiazepines Revenue by Application (2024-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Non-Benzodiazepines Revenue by Application (2024-2034) & (US$ Million)
Table 105. Middle East, Africa and Latin America Non-Benzodiazepines Revenue Grow Rate (CAGR) by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 106. Middle East, Africa and Latin America Non-Benzodiazepines Revenue by Country (2024-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Non-Benzodiazepines Revenue by Country (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Non-Benzodiazepines Sales by Country (2024-2024) & (K Units)
Table 109. Middle East, Africa and Latin America Non-Benzodiazepines Sales by Country (2024-2034) & (K Units)
Table 110. Pfizer Company Information
Table 111. Pfizer Description and Major Businesses
Table 112. Pfizer Non-Benzodiazepines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. Pfizer Non-Benzodiazepines Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Pfizer Recent Developments
Table 115. Teva Pharmaceuticals Company Information
Table 116. Teva Pharmaceuticals Description and Major Businesses
Table 117. Teva Pharmaceuticals Non-Benzodiazepines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 118. Teva Pharmaceuticals Non-Benzodiazepines Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Teva Pharmaceuticals Recent Developments
Table 120. Torrent Pharma Company Information
Table 121. Torrent Pharma Description and Major Businesses
Table 122. Torrent Pharma Non-Benzodiazepines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 123. Torrent Pharma Non-Benzodiazepines Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Torrent Pharma Recent Developments
Table 125. Accord Healthcare Company Information
Table 126. Accord Healthcare Description and Major Businesses
Table 127. Accord Healthcare Non-Benzodiazepines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 128. Accord Healthcare Non-Benzodiazepines Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Accord Healthcare Recent Developments
Table 130. Akorn Company Information
Table 131. Akorn Description and Major Businesses
Table 132. Akorn Non-Benzodiazepines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 133. Akorn Non-Benzodiazepines Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Akorn Recent Developments
Table 135. Apotex Company Information
Table 136. Apotex Description and Major Businesses
Table 137. Apotex Non-Benzodiazepines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 138. Apotex Non-Benzodiazepines Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Apotex Recent Developments
Table 140. Fresenius Kabi Company Information
Table 141. Fresenius Kabi Description and Major Businesses
Table 142. Fresenius Kabi Non-Benzodiazepines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 143. Fresenius Kabi Non-Benzodiazepines Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Fresenius Kabi Recent Developments
Table 145. Hikma Company Information
Table 146. Hikma Description and Major Businesses
Table 147. Hikma Non-Benzodiazepines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 148. Hikma Non-Benzodiazepines Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Hikma Recent Developments
Table 150. Mylan Company Information
Table 151. Mylan Description and Major Businesses
Table 152. Mylan Non-Benzodiazepines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 153. Mylan Non-Benzodiazepines Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Mylan Recent Developments
Table 155. Par Pharmaceuticals Company Information
Table 156. Par Pharmaceuticals Description and Major Businesses
Table 157. Par Pharmaceuticals Non-Benzodiazepines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 158. Par Pharmaceuticals Non-Benzodiazepines Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Par Pharmaceuticals Recent Developments
Table 160. Sandoz Company Information
Table 161. Sandoz Description and Major Businesses
Table 162. Sandoz Non-Benzodiazepines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 163. Sandoz Non-Benzodiazepines Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Sandoz Recent Developments
Table 165. Sun Pharma Company Information
Table 166. Sun Pharma Description and Major Businesses
Table 167. Sun Pharma Non-Benzodiazepines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 168. Sun Pharma Non-Benzodiazepines Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Sun Pharma Recent Developments
Table 170. WG Critical Care Company Information
Table 171. WG Critical Care Description and Major Businesses
Table 172. WG Critical Care Non-Benzodiazepines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 173. WG Critical Care Non-Benzodiazepines Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. WG Critical Care Recent Developments
Table 175. Athenex Company Information
Table 176. Athenex Description and Major Businesses
Table 177. Athenex Non-Benzodiazepines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 178. Athenex Non-Benzodiazepines Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Athenex Recent Developments
Table 180. Chenxin Pharmaceutical Company Information
Table 181. Chenxin Pharmaceutical Description and Major Businesses
Table 182. Chenxin Pharmaceutical Non-Benzodiazepines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 183. Chenxin Pharmaceutical Non-Benzodiazepines Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Chenxin Pharmaceutical Recent Developments
Table 185. Huatai Chenguang Pharmaceutical Company Information
Table 186. Huatai Chenguang Pharmaceutical Description and Major Businesses
Table 187. Huatai Chenguang Pharmaceutical Non-Benzodiazepines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 188. Huatai Chenguang Pharmaceutical Non-Benzodiazepines Product Model Numbers, Pictures, Descriptions and Specifications
Table 189. Huatai Chenguang Pharmaceutical Recent Developments
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Non-Benzodiazepines Distributors List
Table 193. Non-Benzodiazepines Customers List
Table 194. Non-Benzodiazepines Market Trends
Table 195. Non-Benzodiazepines Market Drivers
Table 196. Non-Benzodiazepines Market Challenges
Table 197. Non-Benzodiazepines Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Non-Benzodiazepines Product Picture
Figure 2. Global Non-Benzodiazepines Market Size Growth Rate by Type, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Non-Benzodiazepines Market Share by Type in 2022 & 2034
Figure 4. Dexmedetomidine Product Picture
Figure 5. Zolpidem Product Picture
Figure 6. Eszopiclone Product Picture
Figure 7. Zopiclone Product Picture
Figure 8. other Product Picture
Figure 9. Global Non-Benzodiazepines Market Size Growth Rate by Application, 2024 VS 2022 VS 2034 (US$ Million)
Figure 10. Global Non-Benzodiazepines Market Share by Application in 2022 & 2034
Figure 11. Hospital
Figure 12. Clinic
Figure 13. Other
Figure 14. Non-Benzodiazepines Report Years Considered
Figure 15. Global Non-Benzodiazepines Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 16. Global Non-Benzodiazepines Revenue 2024-2034 (US$ Million)
Figure 17. Global Non-Benzodiazepines Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 18. Global Non-Benzodiazepines Revenue Market Share by Region (2024-2034)
Figure 19. Global Non-Benzodiazepines Sales 2024-2034 ((K Units)
Figure 20. Global Non-Benzodiazepines Sales Market Share by Region (2024-2034)
Figure 21. US & Canada Non-Benzodiazepines Sales YoY (2024-2034) & (K Units)
Figure 22. US & Canada Non-Benzodiazepines Revenue YoY (2024-2034) & (US$ Million)
Figure 23. Europe Non-Benzodiazepines Sales YoY (2024-2034) & (K Units)
Figure 24. Europe Non-Benzodiazepines Revenue YoY (2024-2034) & (US$ Million)
Figure 25. China Non-Benzodiazepines Sales YoY (2024-2034) & (K Units)
Figure 26. China Non-Benzodiazepines Revenue YoY (2024-2034) & (US$ Million)
Figure 27. Asia (excluding China) Non-Benzodiazepines Sales YoY (2024-2034) & (K Units)
Figure 28. Asia (excluding China) Non-Benzodiazepines Revenue YoY (2024-2034) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Non-Benzodiazepines Sales YoY (2024-2034) & (K Units)
Figure 30. Middle East, Africa and Latin America Non-Benzodiazepines Revenue YoY (2024-2034) & (US$ Million)
Figure 31. The Non-Benzodiazepines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 32. The Top 5 and 10 Largest Manufacturers of Non-Benzodiazepines in the World: Market Share by Non-Benzodiazepines Revenue in 2022
Figure 33. Global Non-Benzodiazepines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 34. Global Non-Benzodiazepines Sales Market Share by Type (2024-2034)
Figure 35. Global Non-Benzodiazepines Revenue Market Share by Type (2024-2034)
Figure 36. Global Non-Benzodiazepines Sales Market Share by Application (2024-2034)
Figure 37. Global Non-Benzodiazepines Revenue Market Share by Application (2024-2034)
Figure 38. US & Canada Non-Benzodiazepines Sales Market Share by Type (2024-2034)
Figure 39. US & Canada Non-Benzodiazepines Revenue Market Share by Type (2024-2034)
Figure 40. US & Canada Non-Benzodiazepines Sales Market Share by Application (2024-2034)
Figure 41. US & Canada Non-Benzodiazepines Revenue Market Share by Application (2024-2034)
Figure 42. US & Canada Non-Benzodiazepines Revenue Share by Country (2024-2034)
Figure 43. US & Canada Non-Benzodiazepines Sales Share by Country (2024-2034)
Figure 44. U.S. Non-Benzodiazepines Revenue (2024-2034) & (US$ Million)
Figure 45. Canada Non-Benzodiazepines Revenue (2024-2034) & (US$ Million)
Figure 46. Europe Non-Benzodiazepines Sales Market Share by Type (2024-2034)
Figure 47. Europe Non-Benzodiazepines Revenue Market Share by Type (2024-2034)
Figure 48. Europe Non-Benzodiazepines Sales Market Share by Application (2024-2034)
Figure 49. Europe Non-Benzodiazepines Revenue Market Share by Application (2024-2034)
Figure 50. Europe Non-Benzodiazepines Revenue Share by Country (2024-2034)
Figure 51. Europe Non-Benzodiazepines Sales Share by Country (2024-2034)
Figure 52. Germany Non-Benzodiazepines Revenue (2024-2034) & (US$ Million)
Figure 53. France Non-Benzodiazepines Revenue (2024-2034) & (US$ Million)
Figure 54. U.K. Non-Benzodiazepines Revenue (2024-2034) & (US$ Million)
Figure 55. Italy Non-Benzodiazepines Revenue (2024-2034) & (US$ Million)
Figure 56. Russia Non-Benzodiazepines Revenue (2024-2034) & (US$ Million)
Figure 57. China Non-Benzodiazepines Sales Market Share by Type (2024-2034)
Figure 58. China Non-Benzodiazepines Revenue Market Share by Type (2024-2034)
Figure 59. China Non-Benzodiazepines Sales Market Share by Application (2024-2034)
Figure 60. China Non-Benzodiazepines Revenue Market Share by Application (2024-2034)
Figure 61. Asia Non-Benzodiazepines Sales Market Share by Type (2024-2034)
Figure 62. Asia Non-Benzodiazepines Revenue Market Share by Type (2024-2034)
Figure 63. Asia Non-Benzodiazepines Sales Market Share by Application (2024-2034)
Figure 64. Asia Non-Benzodiazepines Revenue Market Share by Application (2024-2034)
Figure 65. Asia Non-Benzodiazepines Revenue Share by Region (2024-2034)
Figure 66. Asia Non-Benzodiazepines Sales Share by Region (2024-2034)
Figure 67. Japan Non-Benzodiazepines Revenue (2024-2034) & (US$ Million)
Figure 68. South Korea Non-Benzodiazepines Revenue (2024-2034) & (US$ Million)
Figure 69. China Taiwan Non-Benzodiazepines Revenue (2024-2034) & (US$ Million)
Figure 70. Southeast Asia Non-Benzodiazepines Revenue (2024-2034) & (US$ Million)
Figure 71. India Non-Benzodiazepines Revenue (2024-2034) & (US$ Million)
Figure 72. Middle East, Africa and Latin America Non-Benzodiazepines Sales Market Share by Type (2024-2034)
Figure 73. Middle East, Africa and Latin America Non-Benzodiazepines Revenue Market Share by Type (2024-2034)
Figure 74. Middle East, Africa and Latin America Non-Benzodiazepines Sales Market Share by Application (2024-2034)
Figure 75. Middle East, Africa and Latin America Non-Benzodiazepines Revenue Market Share by Application (2024-2034)
Figure 76. Middle East, Africa and Latin America Non-Benzodiazepines Revenue Share by Country (2024-2034)
Figure 77. Middle East, Africa and Latin America Non-Benzodiazepines Sales Share by Country (2024-2034)
Figure 78. Brazil Non-Benzodiazepines Revenue (2024-2034) & (US$ Million)
Figure 79. Mexico Non-Benzodiazepines Revenue (2024-2034) & (US$ Million)
Figure 80. Turkey Non-Benzodiazepines Revenue (2024-2034) & (US$ Million)
Figure 81. Israel Non-Benzodiazepines Revenue (2024-2034) & (US$ Million)
Figure 82. GCC Countries Non-Benzodiazepines Revenue (2024-2034) & (US$ Million)
Figure 83. Non-Benzodiazepines Value Chain
Figure 84. Non-Benzodiazepines Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed